Trial intelligence / Profile preview

Azopt vs Timolol as adjunctive therapy to PGA in glaucoma or ocular hypertension

NCT00300079Phase 4Completed

Sponsor
Alcon Inc.
Start
Sep 2006
Primary completion
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of brinzolamide in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Alcon Inc.. Started Sep 2006; status: completed.

02

Drugs

brinzolamide
03

Conditions

primary open-angle glaucoma (POAG)ocular hypertension

Beyond the preview

Go deeper on NCT00300079.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00300079.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call